Although the results point to the importance of T cell-NF-κB in tumor rejection, we cannot rule out that other signaling pathways downstream of IKKβ or CARMA1 may play a role in addition to, or instead of, NF-κB. The gene discussed is CARD11; the disease is neoplasm.